Association between adefovir dipivoxil treatment and the risk of renal insufficiency in patients with chronic hepatitis B: A meta-analysis

Biomedical Reports
Qiao YangFangfang Lv

Abstract

Adefovir dipivoxil (ADV) is an effective antiviral drug against hepatitis B virus. The renal tolerance of ADV at the currently approved dose of 10 mg daily for the treatment of chronic hepatitis B (CHB) remains controversial. The present meta-analysis was therefore performed to evaluate the renal safety of ADV treatment in patients with CHB. Two independent investigators searched MEDLINE, Embase and China National Knowledge Infrastructure databases for eligible studies published in English or Chinese until June 1, 2014. The Peto odds ratios (Peto ORs) or the rates of each study were analyzed. Seven randomized controlled trials (RCTs), four cohort studies and six single-arm studies were identified. ADV treatment was not associated with a higher incidence of nephrotoxicity in RCTs [Peto OR, 1.781; 95% confidence interval (CI), 0.637-4.979; P=0.271] but appeared to increase nephrotoxicity significantly in cohort studies (Peto OR, 2.682; 95% CI, 1.470-4.894; P=0.001); the significant increase was further observed in CHB patients receiving long-term ADV treatment in cohort studies (Peto OR, 2.275; 95% CI, 1.127-4.593; P=0.022). The analysis based on single-arm studies showed that the rate of renal dysfunction in the ADV-treated pati...Continue Reading

References

Jul 8, 1976·The New England Journal of Medicine·D P ByarJ H Ware
Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Jun 22, 2000·The New England Journal of Medicine·K Benson, A J Hartz
Sep 8, 2001·AIDS·E J FisherUNKNOWN Terry Beirn Community Programs for Clinical Research on AIDS
Feb 28, 2003·The New England Journal of Medicine·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Sep 23, 2003·Drugs·Toni Dando, Greg Plosker
Aug 26, 2004·Kidney International·Hassane IzzedineUNKNOWN Adefovir Dipivoxil International 438 Study Group
May 25, 2005·Health Information and Libraries Journal·Nicola Pearce-Smith, Jo Hunter
Feb 28, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Eugene SchiffUNKNOWN Adefovir Dipivoxil Study 45 Intrnational Investigators Group
Nov 7, 2007·Alimentary Pharmacology & Therapeutics·S G LimUNKNOWN International Investigator Groups for Studies 437 and 438
Apr 25, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maureen M JonasEtienne Sokal
Aug 30, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patrick MarcellinFranck Rousseau
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jun 12, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nghi B HaMindie H Nguyen
Sep 29, 2009·Journal of Gastroenterology and Hepatology·Themistoklis G VassiliadisNikolaos Eugenidis
Jun 28, 2011·Journal of Hepatology·Stefan MaussEva Herrmann
Nov 19, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Spilios ManolakopoulosGeorge V Papatheodoridis
Aug 25, 2012·Transplantation·Pablo R LujanPablo U Massari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.